Predicted protein targets (top 6)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ITGB1 | P05556 | 20/20 | 0.56 |
| ▸ | ITGA5 | P08648 | 20/20 | 0.56 |
| ▸ | ITGB3 | P05106 | 11/20 | 0.56 |
| ▸ | ITGAV | P06756 | 11/20 | 0.56 |
| ▸ | ITGB5 | P18084 | 7/20 | 0.55 |
| ▸ | ITGA2B | P08514 | 3/20 | 0.55 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL5567573 | 0.76 | ITGB1 (0.69) | ITGB1ITGA5ITGB3ITGAVITGB5 | |
| SCHEMBL5567905 | 0.76 | ITGB1 (0.70) | ITGB1ITGA5ITGB3ITGAVITGB5 | |
| SCHEMBL5568652 | 0.76 | ITGB1 (0.67) | ITGB1ITGA5ITGB3ITGAVITGB5 | |
| SCHEMBL5569578 | 0.75 | ITGB1 (0.83) | ITGB1ITGA5ITGB3ITGAVITGB5 | |
| SCHEMBL5568537 | 0.74 | ITGB1 (0.85) | ITGB1ITGA5ITGB3ITGAVITGB5 | |
| SCHEMBL5568351 | 0.73 | ITGB1 (0.70) | ITGB1ITGA5ITGB3ITGAVITGB5 | |
| SCHEMBL5567431 | 0.73 | ITGB1 (0.68) | ITGB1ITGA5ITGB3ITGAVITGB5 | |
| SCHEMBL5569482 | 0.73 | ITGB1 (0.70) | ITGB1ITGA5ITGB3ITGAVITGB5 | |
| SCHEMBL5568077 | 0.73 | ITGB1 (0.71) | ITGB1ITGA5ITGB3ITGAVITGB5 | |
| SCHEMBL5568506 | 0.73 | ITGB1 (0.74) | ITGB1ITGA5ITGB3ITGAVITGB5 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 18 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-2780022-A1 | PHARMACEUTICAL PREPARATIONS OF HUMAN RPE CELLS AND USES THEREOF | Advanced Cell Technology, Inc. (US) | 2014-09-24 | — | — | EP | claimed |
| WO-2013074681-A9 | PHARMACEUTICAL PREPARATIONS OF HUMAN RPE CELLS AND USES THEREOF | ADVANCED CELL TECHNOLOGY, INC. (US) | 2013-11-28 | — | — | WO | claimed |
| US-20130195806-A1 | PHARMACEUTICAL PREPARATIONS OF HUMAN RPE CELLS AND USES THEREOF | ADVANCED CELL TECHNOLOGY, INC. (US) | 2013-08-01 | — | — | US | claimed |
| WO-2013074681-A1 | PHARMACEUTICAL PREPARATIONS OF HUMAN RPE CELLS AND USES THEREOF | ADVANCED CELL TECHNOLOGY, INC. (US) | 2013-05-23 | — | — | WO | claimed |
| US-20110110932-A1 | COMBINATION TREATMENT FOR OCULAR DISEASES | OPHTHOTECH CORP. (US) | 2011-05-12 | — | — | US | claimed |
| WO-2024044134-A1 | PHOTORECEPTOR RESCUE CELL (PRC) COMPOSITIONS AND METHODS FOR TREATMENT OF OCULAR DISORDERS | ASTELLAS INSTITUTE FOR REGENERATIVE MEDICINE (US) | 2024-02-29 | — | — | WO | disclosed |
| US-11241460-B2 | Photoreceptors and photoreceptor progenitors produced from pluripotent stem cells | ASTELLAS INSTITUTE FOR REGENERATIVE MEDICINE (US) | 2022-02-08 | — | — | US | disclosed |
| US-20200405767-A1 | PHARMACEUTICAL PREPARATIONS OF HUMAN RPE CELLS AND USES THEREOF | ASTELLAS INSTITUTE FOR REGENERATIVE MEDICINE (US) | 2020-12-31 | — | — | US | disclosed |
| EP-3563860-A1 | PHARMACEUTICAL PREPARATIONS OF HUMAN RPE CELLS AND USES THEREOF | Astellas Institute for Regenerative Medicine (US) | 2019-11-06 | — | — | EP | disclosed |
| EP-2780022-B1 | PHARMACEUTICAL PREPARATIONS OF HUMAN RPE CELLS AND USES THEREOF | ASTELLAS INST FOR REGENERATIVE MEDICINE (US) | 2019-06-05 | — | — | EP | disclosed |
| US-20160175362-A1 | PHOTORECEPTORS AND PHOTORECEPTOR PROGENITORS PRODUCED FROM PLURIPOTENT STEM CELLS | OCATA THERAPEUTICS, INC. (US) | 2016-06-23 | — | — | US | disclosed |
| US-20160175361-A1 | PHOTORECEPTORS AND PHOTORECEPTOR PROGENITORS PRODUCED FROM PLURIPOTENT STEM CELLS | ADVANCED CELL TECHNOLOGY, INC. (US) | 2016-06-23 | — | — | US | disclosed |
| US-20150366915-A1 | PHARMACEUTICAL PREPARATIONS OF HUMAN RPE CELLS AND USES THEREOF | OCATA THERAPEUTICS, INC. (US) | 2015-12-24 | — | — | US | disclosed |
| EP-2780022-A1 | PHARMACEUTICAL PREPARATIONS OF HUMAN RPE CELLS AND USES THEREOF | Advanced Cell Technology, Inc. (US) | 2014-09-24 | — | — | EP | disclosed |
| WO-2013074681-A9 | PHARMACEUTICAL PREPARATIONS OF HUMAN RPE CELLS AND USES THEREOF | ADVANCED CELL TECHNOLOGY, INC. (US) | 2013-11-28 | — | — | WO | disclosed |
| US-20130195806-A1 | PHARMACEUTICAL PREPARATIONS OF HUMAN RPE CELLS AND USES THEREOF | ADVANCED CELL TECHNOLOGY, INC. (US) | 2013-08-01 | — | — | US | disclosed |
| WO-2013074681-A1 | PHARMACEUTICAL PREPARATIONS OF HUMAN RPE CELLS AND USES THEREOF | ADVANCED CELL TECHNOLOGY, INC. (US) | 2013-05-23 | — | — | WO | disclosed |
| US-20110110932-A1 | COMBINATION TREATMENT FOR OCULAR DISEASES | OPHTHOTECH CORP. (US) | 2011-05-12 | — | — | US | disclosed |